Categories AlphaGraphs, Earnings, Health Care
Key highlights from Moderna’s (MRNA) Q1 2023 earnings results
Moderna, Inc. (NASDAQ: MRNA) reported first quarter 2023 earnings results today.
Total revenue was $1.9 billion, compared to $6.1 billion in the same period a year ago, mainly due to a drop in sales of the company’s COVID-19 vaccines.
Product sales were $1.8 billion, down 69% compared to the prior-year period, driven mainly by lower sales volume.
Net income was $79 million, or $0.19 per share, compared to $3.7 billion, or $8.58 per share, last year.
The company expects total product sales in the first half of 2023 to be approx. $2 billion. For the second quarter of 2023, sales are expected to be $0.2-0.3 billion.
Most Popular
CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results
Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
